Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence
Cihangir Duy, Meng Li, Matt Teater, et al.
Cancer Discovery (2021) Vol. 11, Iss. 6, pp. 1542-1561
Open Access | Times Cited: 176

Showing 1-25 of 176 citing articles:

Senescence and cancer — role and therapeutic opportunities
Clemens A. Schmitt, Boshi Wang, Marco Demaria
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 10, pp. 619-636
Open Access | Times Cited: 439
Non-genetic determinants of malignant clonal fitness at single-cell resolution
Katie Fennell, Dane Vassiliadis, Enid Y.N. Lam, et al.
Nature (2021) Vol. 601, Iss. 7891, pp. 125-131
Closed Access | Times Cited: 116
Leukemic stem cells and therapy resistance in acute myeloid leukemia
Patrick Stelmach, Andreas Trumpp
Haematologica (2023) Vol. 108, Iss. 2, pp. 353-366
Open Access | Times Cited: 97
Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action
Caitlin M. Tilsed, Scott Fisher, Anna K. Nowak, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 93
Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer
Martina Troiani, Manuel Colucci, Mariantonietta D’Ambrosio, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 79
Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy
Hanxin Liu, Qixia Xu, Halidan Wufuer, et al.
Aging Cell (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 69
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia
Matteo Maria Naldini, Gabriele Casirati, Matteo Barcella, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax
Alexander Waclawiczek, Aino‐Maija Leppä, Simon Renders, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1408-1427
Open Access | Times Cited: 41
Senolytics for Cancer Therapy: Is All that Glitters Really Gold?
Valerie J. Carpenter, Tareq Saleh, David A. Gewirtz
Cancers (2021) Vol. 13, Iss. 4, pp. 723-723
Open Access | Times Cited: 88
Multipotent progenitors and hematopoietic stem cells arise independently from hemogenic endothelium in the mouse embryo
Tessa Dignum, Barbara Varnum‐Finney, Sanjay Srivatsan, et al.
Cell Reports (2021) Vol. 36, Iss. 11, pp. 109675-109675
Open Access | Times Cited: 83
Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer
Chewei Anderson Chang, Jayu Jen, Shaowen Jiang, et al.
Cancer Discovery (2021) Vol. 12, Iss. 4, pp. 1022-1045
Open Access | Times Cited: 72
Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia
Sergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 21
Open Access | Times Cited: 62
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies
Joshua Bennett, Daniel T. Starczynowski
Current Opinion in Hematology (2021) Vol. 29, Iss. 1, pp. 8-19
Open Access | Times Cited: 61
Targeting senescence as an anticancer therapy
Laura Bousset, Jesús Gil
Molecular Oncology (2022) Vol. 16, Iss. 21, pp. 3855-3880
Open Access | Times Cited: 58
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia
Kening Li, Yuxin Du, Yun Cai, et al.
Leukemia (2022) Vol. 37, Iss. 2, pp. 308-325
Open Access | Times Cited: 52
TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity
Tomoya Muto, María Guillamot, Jennifer Yeung, et al.
Cell stem cell (2022) Vol. 29, Iss. 2, pp. 298-314.e9
Open Access | Times Cited: 41
Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
Jialan Niu, Danyue Peng, Lingbo Liu
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 40
CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
Thomas Farge, Jean Nakhle, Damien Lagarde, et al.
Cancer Research (2023) Vol. 83, Iss. 17, pp. 2824-2838
Open Access | Times Cited: 30
Scalable querying of human cell atlases via a foundational model reveals commonalities across fibrosis-associated macrophages
Graham Heimberg, Tony Kuo, Daryle J. DePianto, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 29
Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells
Yannan Jia, Lina Han, Cassandra L. Ramage, et al.
Haematologica (2023) Vol. 108, Iss. 10, pp. 2626-2638
Open Access | Times Cited: 27
Early response evaluation by single cell signaling profiling in acute myeloid leukemia
Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML
Yongping Zhang, Shuting Jiang, Fuhong He, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 22
SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming
Xi Xu, Yanhui Yu, Wendy Zhang, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 3, pp. 464-477
Closed Access | Times Cited: 14
Convergent epigenetic evolution drives relapse in acute myeloid leukemia
Kevin A. Nuno, Armon Azizi, Thomas Koehnke, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 13
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities
Mariangela Russo, Mengnuo Chen, Elisa Mariella, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 694-717
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top